• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在. 中候选减毒活疫苗的复制动力学

Replication Kinetics of a Candidate Live-Attenuated Vaccine for Cache Valley Virus in .

机构信息

Department of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, Kansas State University, Manhattan, Kansas, USA.

Biosecurity Research Institute, Kansas State University, Manhattan, Kansas, USA.

出版信息

Vector Borne Zoonotic Dis. 2022 Nov;22(11):553-558. doi: 10.1089/vbz.2022.0053.

DOI:10.1089/vbz.2022.0053
PMID:36354965
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9700352/
Abstract

The emergence or re-emergence of several orthobunyaviruses (order: ; family: ), including Cache Valley virus (CVV) and Oropouche virus, warrants the development and evaluation of candidate live-attenuated vaccines (LAVs). Ideally, these vaccines would elicit long-lasting immunity with one single immunization. Since the deletion of two virulence factors, NSs and NSm, has been shown to attenuate the virulence phenotype of orthobunyaviruses, phleboviruses, and nairoviruses, genetic manipulation of the viral genome is considered an effective strategy for the rational design of candidate LAVs for bunyaviruses across multiple families. In addition, the deletion of Rift Valley fever virus NSs and NSm genes has been shown to reduce transmission by mosquitoes. In this study, the ability of a CVV mutant lacking the NSs and NSm genes (2delCVV) to replicate in intrathoracically injected was compared with the parental wild-type CVV (wtCVV) 6V633 strain. In contrast to the robust replication of wtCVV in injected mosquitoes, the multiplication kinetics of the 2delCVV mutant was reduced by more than a 100-fold. These results suggest that the deletion of NSm and NSs genes is a feasible approach to rationally design candidate orthobunyavirus LAVs that are highly attenuated in mosquitoes and, therefore, pose little risk of reversion to virulence and transmission.

摘要

几种正粘病毒(目:;科:)的出现或再现,包括卡奇谷病毒(CVV)和奥罗普切病毒,这就需要开发和评估候选减毒活疫苗(LAV)。理想情况下,这些疫苗只需一次免疫就能引发持久的免疫力。由于删除两个毒力因子 NSs 和 NSm 已被证明能减弱正粘病毒、布尼亚病毒和内罗病毒的毒力表型,因此对病毒基因组进行遗传操作被认为是合理设计跨多个家族布尼亚病毒候选 LAV 的有效策略。此外,删除裂谷热病毒 NSs 和 NSm 基因已被证明能降低蚊子的传播能力。在这项研究中,比较了缺乏 NSs 和 NSm 基因的 CVV 突变体(2delCVV)与亲本野生型 CVV(wtCVV)6V633 株在胸腔内注射后的复制能力。与 wtCVV 在注射蚊子中强大的复制能力形成对比的是,2delCVV 突变体的倍增动力学减少了 100 多倍。这些结果表明,删除 NSm 和 NSs 基因是合理设计候选正粘病毒 LAV 的可行方法,这种 LAV 在蚊子中高度减毒,因此几乎没有毒力和传播能力恢复的风险。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d2/9700352/0e0c1a96b075/vbz.2022.0053_figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d2/9700352/0e0c1a96b075/vbz.2022.0053_figure1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/72d2/9700352/0e0c1a96b075/vbz.2022.0053_figure1.jpg

相似文献

1
Replication Kinetics of a Candidate Live-Attenuated Vaccine for Cache Valley Virus in .在. 中候选减毒活疫苗的复制动力学
Vector Borne Zoonotic Dis. 2022 Nov;22(11):553-558. doi: 10.1089/vbz.2022.0053.
2
Infection and transmission of Rift Valley fever viruses lacking the NSs and/or NSm genes in mosquitoes: potential role for NSm in mosquito infection.在蚊子中缺失 NSs 和/或 NSm 基因的裂谷热病毒的感染和传播:NSm 在蚊子感染中的潜在作用。
PLoS Negl Trop Dis. 2012;6(5):e1639. doi: 10.1371/journal.pntd.0001639. Epub 2012 May 1.
3
Comparison of Immunogenicity Between a Candidate Live Attenuated Vaccine and an Inactivated Vaccine for Cache Valley Virus.候选活疫苗与灭活疫苗对卡奇谷病毒免疫原性的比较。
Viral Immunol. 2023 Jan;36(1):41-47. doi: 10.1089/vim.2022.0103. Epub 2023 Jan 9.
4
Infection and transmission of Cache Valley virus by Aedes albopictus and Aedes aegypti mosquitoes.白纹伊蚊和埃及伊蚊感染和传播卡谷病毒。
Parasit Vectors. 2019 Jul 31;12(1):384. doi: 10.1186/s13071-019-3643-0.
5
Deletion of the NSm virulence gene of Rift Valley fever virus inhibits virus replication in and dissemination from the midgut of Aedes aegypti mosquitoes.裂谷热病毒的 NSm 毒力基因缺失可抑制埃及伊蚊中肠内的病毒复制和传播。
PLoS Negl Trop Dis. 2014 Feb 13;8(2):e2670. doi: 10.1371/journal.pntd.0002670. eCollection 2014 Feb.
6
and Cache Valley virus: a new threat for virus transmission in New York State.以及卡奇谷病毒:纽约州病毒传播的新威胁。
Emerg Microbes Infect. 2022 Dec;11(1):741-748. doi: 10.1080/22221751.2022.2044733.
7
Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes.裂谷热人类候选疫苗(DDVax)在蚊子中的安全性研究。
Transbound Emerg Dis. 2022 Sep;69(5):2621-2633. doi: 10.1111/tbed.14415. Epub 2022 Jan 5.
8
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L Segments.裂谷热病毒MP-12疫苗通过S、M和L基因片段的部分减毒组合而完全减毒。
J Virol. 2015 Jul;89(14):7262-76. doi: 10.1128/JVI.00135-15. Epub 2015 May 6.
9
Distinct Pathological Changes in Preweaning Mice Infected with Live-Attenuated Rift Valley Fever Virus Strains.新生期感染减毒裂谷热病毒株的小鼠存在明显的病理学改变。
Viruses. 2024 Jun 21;16(7):999. doi: 10.3390/v16070999.
10
Vector competence of Virginia mosquitoes for Zika and Cache Valley viruses.弗吉尼亚州蚊虫对寨卡病毒和卡什谷病毒的媒介效能。
Parasit Vectors. 2020 Apr 10;13(1):188. doi: 10.1186/s13071-020-04042-0.

引用本文的文献

1
Mysterious Oropouche virus: Transmission, symptoms, and control.神秘的奥罗普切病毒:传播、症状与防控
Infect Med (Beijing). 2025 Mar 17;4(2):100177. doi: 10.1016/j.imj.2025.100177. eCollection 2025 Jun.
2
Investigating the reassortment potential and pathogenicity of the S segment in Akabane virus using a reverse genetics system.利用反向遗传学系统研究赤羽病毒S基因片段的重配潜力和致病性。
BMC Vet Res. 2025 Jan 15;21(1):20. doi: 10.1186/s12917-024-04459-0.
3
Addressing the emerging threat of Oropouche virus: implications and public health responses for healthcare systems.

本文引用的文献

1
Comparison of Immunogenicity Between a Candidate Live Attenuated Vaccine and an Inactivated Vaccine for Cache Valley Virus.候选活疫苗与灭活疫苗对卡奇谷病毒免疫原性的比较。
Viral Immunol. 2023 Jan;36(1):41-47. doi: 10.1089/vim.2022.0103. Epub 2023 Jan 9.
2
Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism.黄热病毒包膜蛋白对野生型和疫苗表位以及组织嗜性的影响。
NPJ Vaccines. 2022 Mar 23;7(1):39. doi: 10.1038/s41541-022-00460-6.
3
and Cache Valley virus: a new threat for virus transmission in New York State.
应对奥罗普切病毒的新威胁:对医疗系统的影响及公共卫生应对措施
Trop Dis Travel Med Vaccines. 2025 Jan 2;11(1):1. doi: 10.1186/s40794-024-00236-x.
4
Oropouche virus: A neglected global arboviral threat.奥罗普切病毒:被忽视的全球性虫媒病毒威胁。
Virus Res. 2024 Mar;341:199318. doi: 10.1016/j.virusres.2024.199318. Epub 2024 Jan 16.
以及卡奇谷病毒:纽约州病毒传播的新威胁。
Emerg Microbes Infect. 2022 Dec;11(1):741-748. doi: 10.1080/22221751.2022.2044733.
4
Safety study of Rift Valley Fever human vaccine candidate (DDVax) in mosquitoes.裂谷热人类候选疫苗(DDVax)在蚊子中的安全性研究。
Transbound Emerg Dis. 2022 Sep;69(5):2621-2633. doi: 10.1111/tbed.14415. Epub 2022 Jan 5.
5
Novel murine models for studying Cache Valley virus pathogenesis and transmission.研究 Cache Valley 病毒发病机制和传播的新型鼠类模型。
Emerg Microbes Infect. 2021 Dec;10(1):1649-1659. doi: 10.1080/22221751.2021.1965497.
6
Rationally Attenuated Vaccines for Venezuelan Equine Encephalitis Protect Against Epidemic Strains with a Single Dose.用于委内瑞拉马脑炎的合理减毒疫苗单剂量即可预防流行毒株。
Vaccines (Basel). 2020 Sep 2;8(3):497. doi: 10.3390/vaccines8030497.
7
SARS-CoV-2 failure to infect or replicate in mosquitoes: an extreme challenge.SARS-CoV-2 无法感染或在蚊子中复制:一个极端的挑战。
Sci Rep. 2020 Jul 17;10(1):11915. doi: 10.1038/s41598-020-68882-7.
8
Theoretical risk of genetic reassortment should not impede development of live, attenuated Rift Valley fever (RVF) vaccines commentary on the draft WHO RVF Target Product Profile.基因重配的理论风险不应阻碍裂谷热(RVF)减毒活疫苗的研发——对世界卫生组织RVF目标产品简介草案的评论
Vaccine X. 2020 Apr 9;5:100060. doi: 10.1016/j.jvacx.2020.100060. eCollection 2020 Aug 7.
9
ICTV Virus Taxonomy Profile: .国际病毒分类委员会病毒分类概况:.
J Gen Virol. 2020 Jan;101(1):1-2. doi: 10.1099/jgv.0.001365.
10
Japanese encephalitis vaccine-specific envelope protein E138K mutation does not attenuate virulence of West Nile virus.日本脑炎疫苗特异性包膜蛋白E138K突变不会减弱西尼罗河病毒的毒力。
NPJ Vaccines. 2019 Dec 5;4:50. doi: 10.1038/s41541-019-0146-0. eCollection 2019.